Biotie Therapies Corp Company Profile (NASDAQ:BITI)

About Biotie Therapies Corp (NASDAQ:BITI)

Biotie Therapies Corp logoBiotie Therapies Corp is a Finland-based drug development company focused on developing products for neurodegenerative and psychiatric disorders. The Company's lead market product is Selincro (nalmefene), a therapeutic for alcohol dependence that is rolled out across Europe by its partner Lundbeck. Its product pipeline includes tozadenant, a therapeutic for Parkinson's disease that is in Phase Three development; and two additional compounds in Phase Two development that treat cognitive disorders, namely: SYN120, an orally administered compound therapeutic for Parkinson's disease dementia, and BTT1023, a human monoclonal antibody targeting compound therapeutic for primary sclerosing cholangitis. The Company operates as a subsidiary of Biotie Therapies Corp.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BITI
  • CUSIP: N/A
  • Web: www.biotie.com/
Average Prices:
  • 50 Day Moving Avg: $26.42
  • 200 Day Moving Avg: $22.73
  • 52 Week Range: $12.43 - $27.96
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.87
  • P/E Growth: 0.00
Misc:
  • Average Volume: 10,392 shs.
 

Frequently Asked Questions for Biotie Therapies Corp (NASDAQ:BITI)

What is Biotie Therapies Corp's stock symbol?

Biotie Therapies Corp trades on the NASDAQ under the ticker symbol "BITI."

Who are some of Biotie Therapies Corp's key competitors?

When did Biotie Therapies Corp IPO?

(BITI) raised $56 million in an initial public offering on Thursday, June 11th 2015. The company issued 3,800,000 shares at $14.82 per share. RBC Capital Markets and Stifel acted as the underwriters for the IPO and JMP Securities and Roth Capital Partners were co-managers.

How do I buy Biotie Therapies Corp stock?

Shares of Biotie Therapies Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biotie Therapies Corp's stock price today?

One share of Biotie Therapies Corp stock can currently be purchased for approximately $25.80.


MarketBeat Community Rating for Biotie Therapies Corp (NASDAQ BITI)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  80
MarketBeat's community ratings are surveys of what our community members think about Biotie Therapies Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Biotie Therapies Corp (NASDAQ:BITI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biotie Therapies Corp (NASDAQ:BITI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/21/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$35.00 -> $25.60N/AView Rating Details
1/19/2016Roth CapitalDowngradeBuy -> NeutralN/AView Rating Details
1/19/2016Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for Biotie Therapies Corp (NASDAQ:BITI)
Earnings by Quarter for Biotie Therapies Corp (NASDAQ:BITI)
Earnings History by Quarter for Biotie Therapies Corp (NASDAQ BITI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/20/2015Q2 2015($1.10)($1.77)$1.01 million$1.47 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biotie Therapies Corp (NASDAQ:BITI)
Current Year EPS Consensus Estimate: $-3.30 EPS
Next Year EPS Consensus Estimate: $-2.91 EPS

Dividends

Dividend History for Biotie Therapies Corp (NASDAQ:BITI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biotie Therapies Corp (NASDAQ:BITI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Biotie Therapies Corp (NASDAQ:BITI)
Latest Headlines for Biotie Therapies Corp (NASDAQ:BITI)
Source:
DateHeadline
americanbankingnews.com logoBiotie Therapies Corp (BITI) Earns News Impact Score of 0.56
www.americanbankingnews.com - April 28 at 8:08 AM
finance.yahoo.com logoACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST
finance.yahoo.com - October 27 at 4:07 PM
finance.yahoo.com logoARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED
finance.yahoo.com - September 26 at 8:36 AM
finance.yahoo.com logoBiotie Therapies Corp.'s Interim Report for the reporting period January 1 - June 30, 2016
finance.yahoo.com - July 28 at 2:02 AM
finance.yahoo.com logoCHANGES IN THE MANAGEMENT TEAM
finance.yahoo.com - June 29 at 2:16 AM
finance.yahoo.com logoChange in Biotie Therapies' Financial Reporting Calendar 2016
finance.yahoo.com - June 21 at 10:02 AM
finance.yahoo.com logoTRUSTEE APPOINTED FOR THE REDEMPTION PROCEEDINGS CONCERNING BIOTIE'S MINORITY SHARES
finance.yahoo.com - June 10 at 1:02 AM
finance.yahoo.com logoNORDEA BANK FINLAND PLC'S MARKET-MAKING FOR BIOTIE THERAPIES CORP.'S SHARE ENDS
finance.yahoo.com - May 18 at 11:22 AM
finance.yahoo.com logo4:11 am Biotie Therapies reports Q1 results
finance.yahoo.com - May 12 at 4:11 AM
finance.yahoo.com logoBiotie Interim Report 1 January - 31 March 2016
finance.yahoo.com - May 12 at 2:03 AM
finance.yahoo.com logoRESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD
finance.yahoo.com - May 3 at 9:33 AM
finance.yahoo.com logoFINAL RESULTS OF THE SUBSEQUENT OFFER PERIOD OF ACORDA'S TENDER OFFER FOR ALL SECURITIES IN BIOTIE
finance.yahoo.com - May 2 at 9:43 AM
finance.yahoo.com logoFinal Results of the Subsequent Offer Period of Acorda Therapeutics' Tender Offer for All of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp.
finance.yahoo.com - May 2 at 9:02 AM
finance.yahoo.com logoACORDA THERAPEUTICS TO COMMENCE A COMPULSORY REDEMPTION PROCEEDING IN RESPECT OF THE REMAINING BIOTIE THERAPIES CORP. SHARES
finance.yahoo.com - April 20 at 9:52 AM
finance.yahoo.com logoCompletion of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Matters Related Thereto
finance.yahoo.com - April 18 at 4:01 PM
finanznachrichten.de logoBiotie Therapies Oyj: FINAL RESULTS OF ACORDA'S TENDER OFFER AND COMMENCEMENT OF A SUBSEQUENT OFFER PERIOD
www.finanznachrichten.de - April 13 at 2:35 PM
finance.yahoo.com logoFINAL RESULTS OF ACORDA'S TENDER OFFER AND COMMENCEMENT OF A SUBSEQUENT OFFER PERIOD
finance.yahoo.com - April 13 at 10:13 AM
finance.yahoo.com logoFinal Results of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Commencement of a Subsequent Offer
finance.yahoo.com - April 13 at 9:00 AM
finance.yahoo.com logoDisclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act
finance.yahoo.com - April 12 at 9:22 AM
finance.yahoo.com logoINVITATION TO THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP.
finance.yahoo.com - April 12 at 2:02 AM
finance.yahoo.com logoACORDA ANNOUNCES PRELIMINARY TENDER OFFER RESULTS AND ACCEPTANCE OF THE SECURITIES IN BIOTIE TENDERED IN TENDER OFFER
finance.yahoo.com - April 11 at 10:02 AM
finance.yahoo.com logoAcorda Therapeutics Announces Preliminary Tender Offer Results and Acceptance of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. Tendered in Tender Offer
finance.yahoo.com - April 11 at 8:59 AM
finance.yahoo.com logoBIOTIE THERAPIES CORP. Financials
finance.yahoo.com - March 26 at 1:04 PM
globenewswire.com logoACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER ... - GlobeNewswire (press release)
globenewswire.com - March 23 at 1:00 PM
finance.yahoo.com logoACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 22 MARCH 2016
finance.yahoo.com - March 22 at 8:22 AM
finance.yahoo.com logoAcorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Co
finance.yahoo.com - March 22 at 8:03 AM
finance.yahoo.com logoBiotie's Financial Statement Report and Corporate Governance Statement 2015 published
finance.yahoo.com - March 22 at 4:02 AM
finance.yahoo.com logoBiotie Therapies downgraded by RBC Capital Mkts
finance.yahoo.com - March 21 at 6:11 AM
finance.yahoo.com logoACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 18 MARCH 2016
finance.yahoo.com - March 18 at 9:43 AM
finance.yahoo.com logoAcorda Therapeutics Supplements Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies on 18
finance.yahoo.com - March 18 at 9:03 AM
finance.yahoo.com logoBiotie Financial Statement Release 2015
finance.yahoo.com - March 18 at 3:03 AM
finance.yahoo.com logoTHE FINNISH FINANCIAL SUPERVISORY AUTHORITY HAS APPROVED THE TENDER OFFER DOCUMENT, ACORDA WILL COMMENCE THE VOLUNTARY PUBLIC TENDER OFFER ON 11 MARCH 2016
finance.yahoo.com - March 10 at 10:47 AM
finance.yahoo.com logoAcorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. on 11 March 2016
finance.yahoo.com - March 10 at 8:40 AM
finance.yahoo.com logoCHANGE IN THE TIME OF BIOTIE THERAPIES' ANNUAL GENERAL MEETING 2016
finance.yahoo.com - March 4 at 11:42 AM
finance.yahoo.com logoAcorda Has Filed Tender Offer Document Relating to Public Tender Offer For Biotie Therapies with Finnish Financial Supervisory Authority
finance.yahoo.com - March 3 at 1:30 AM
finance.yahoo.com logoU.S. antitrust regulation waiting period relating to tender offer has expired
finance.yahoo.com - February 17 at 2:04 AM
finance.yahoo.com logoAcorda Announces Expiration of the Hart-Scott-Rodino Waiting Period for Its Tender Offer for Biotie Therapies
finance.yahoo.com - February 17 at 1:30 AM
finance.yahoo.com logoBiotie Therapies Soars on $363M Buyout Deal with Acorda
finance.yahoo.com - January 20 at 4:25 PM
finance.yahoo.com logoBiotie Therapies Soars on $363M Buyout Deal with Acorda
finance.yahoo.com - January 20 at 4:25 PM
finance.yahoo.com logoBiotie Therapies (BITI) Catches Eye: Stock Moves Up 86.5%
finance.yahoo.com - January 20 at 8:15 AM
finance.yahoo.com logoBiotie Therapies (BITI) Catches Eye: Stock Moves Up 86.5%
finance.yahoo.com - January 20 at 8:15 AM
finance.yahoo.com logoAcorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development
finance.yahoo.com - January 19 at 9:40 AM
finance.yahoo.com logoAcorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development
finance.yahoo.com - January 19 at 9:40 AM

Social

Chart

Biotie Therapies Corp (BITI) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff